Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum.


Journal

The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005

Informations de publication

Date de publication:
01 Nov 2022
Historique:
pubmed: 5 8 2022
medline: 19 10 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

Sweat gland carcinoma with neuroendocrine differentiation (SCAND) is a newly proposed tumor entity of primary cutaneous apocrine/eccrine adnexal tumor with neuroendocrine differentiation. The histopathologic variations are not yet well known. In this article, we present a case of SCAND mimicking male breast cancer and syringocystadenocarcinoma papilliferum. A 68-year-old man presented with a reddish 12-mm nodule on his left areola. No lymph node or distant metastases were observed. The patient was disease free 1 year and 9 months after the tumor was surgically resected but died of cerebral hemorrhage. Histopathological examination revealed a predominantly intradermal tumor with marked syringotropism, mimicking a component of mammary ductal carcinoma in situ. In addition, another tissue section displayed a cup-shaped papillated tumor with syringocystadenocarcinoma papilliferum-like features, which were also seen because of marked syringotropism. Diffuse immunoexpression of cytokeratin 7, cytokeratin 19, chromogranin A, synaptophysin, INSM1, estrogen receptor, carcinoembryonic antigen, epithelial membrane antigen, and GATA3 was observed in the tumor, but no BRAF immunoexpression was seen. The present case would help us to understand the histopathological variation and differential diagnosis of SCAND. The histopathological diagnosis of male breast cancer or syringocystadenocarcinoma papilliferum should be made by ruling out SCAND.

Identifiants

pubmed: 35925548
doi: 10.1097/DAD.0000000000002262
pii: 00000372-202211000-00014
doi:

Substances chimiques

Chromogranin A 0
Keratin-19 0
Keratin-7 0
Mucin-1 0
Receptors, Estrogen 0
Repressor Proteins 0
Synaptophysin 0
INSM1 protein, human 147955-03-1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

850-854

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Goto K, Kukita Y, Honma K, et al. Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis. Mod Pathol. 2022;35:33–43.
Goto K, Anan T, Nakatsuka T, et al. Low-grade neuroendocrine carcinoma of the skin (primary cutaneous carcinoid tumor) as a distinctive entity of cutaneous neuroendocrine tumors: a clinicopathologic study of 3 cases with literature review. Am J Dermatopathol. 2017;39:250–258.
Chen TY, Morrison AO, Susa J, et al. Primary low-grade neuroendocrine carcinoma of the skin: an exceedingly rare entity. J Cutan Pathol. 2017;44:978–981.
Okabayashi A, Nakagawa K, Shimizu N, et al. Case of low-grade neuroendocrine carcinoma of the skin presenting metastases to lymph nodes and peritoneum. J Dermatol. 2019;46:720–723.
Foschini MP, Fox SB, Shaaban AM. Invasive carcinoma. In: WHO Classification of Tumours Editorial Board, eds Breast Tumours. World Health Organization Classification of Tumours. 5th ed Lyon, France: IARC Press, 2019:257–259.
Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604.
Matsuda M, Iwase T, Yoshimoto Y, et al. Male breast cancer: clinicopathological features and time trends. J Jpn Soc Clin Surg. 1997;58:513–518. [in Japanese].
Sundaram S, Prathiba D, Rao S, et al. Solid variant of papillary carcinoma of nipple: an under recognized entity. Indian J Pathol Microbiol. 2010;53:537–540.
Tacchini D, Vassallo L, Butorano MAGM, et al. Solid papillary carcinoma of the nipple: an in situ carcinoma or an expansive growth tumor? Pathologica. 2016;108:136–139.
Domoto H, Watanabe A, Sakata M, et al. Invasive solid papillary carcinoma of the nipple with pagetoid extension and nodal metastasis. Int J Surg Pathol. 2018;26:573–577.
Kazakov DV, Requena L, Kutzner H, et al. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature. Am J Dermatopathol. 2010;32:340–347.
Zhang Y, Kong YY, Cai X, et al. Syringocystadenocarcinoma papilliferum: clinicopathologic analysis of 10 cases. J Cutan Pathol. 2017;44:538–543.
Konstantinova AM, Kacerovska D, Stewart CJ, et al. Syringocystadenocarcinoma papilliferum in situ-like changes in extramammary Paget disease: a report of 11 cases. Am J Dermatopathol. 2016;38:882–886.
Sasaki Y, Goto K, Sugino T, et al. Characteristic clinicopathological features of secondary extramammary Paget disease with underlying anorectal adenocarcinoma: evenly circumferential perianal distribution, fibroepithelioma of Pinkus-like changes, and subepidermal mucin deposits without invasive tumor cells. Am J Dermatopathol. 2021;43:721–726.
Flieder A, Koerner FC, Pilch BZ, et al. Endocrine mucin-producing sweat gland carcinoma: a cutaneous neoplasm analogous to solid papillary carcinoma of breast. Am J Surg Pathol. 1997;21:1501–1506.
Zembowicz A, Garcia CF, Tannous ZS, et al. Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol. 2005;29:1330–1339.
Tsai JH, Hsiao TL, Chen YY, et al. Endocrine mucin-producing sweat gland carcinoma occurring on extra-facial site: a case report. J Cutan Pathol. 2015;41:544–547.
Fernandez-Flores A. Considerations before accepting an extra-facial location of endocrine mucin-producing sweat gland carcinoma. J Cutan Pathol. 2015;42:297–298.
Held L, Ruetten A, Kutzner H, et al. Endocrine mucin-producing sweat gland carcinoma: a clinicopathologic, immunohistochemical, and molecular analysis of 11 cases with emphasis on MYB immunoexpression. J Cutan Pathol. 2018;45:674–680.
Qin H, Moore RF, Ho CY, et al. Endocrine mucin-producing sweat gland carcinoma: a study of 11 cases with molecular analysis. J Cutan Pathol. 2018;45:681–687.
Agni M, Raven ML, Bowen RC, et al. An update on endocrine mucin-producing sweat gland carcinoma: clinicopathologic study of 63 cases and comparative analysis. Am J Surg Pathol. 2020;44:1005–1016.

Auteurs

Shota Bun (S)

Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan.
Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.

Keisuke Goto (K)

Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
Department of Pathology, Itabashi Central Clinical Laboratory, Tokyo, Japan.
Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
Department of Diagnostic Pathology, Osaka National Hospital, Osaka, Japan.
Department of Dermatology, Hyogo Cancer Center, Akashi, Japan; and.
Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.

Takuma Oishi (T)

Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.

Yoshio Kiyohara (Y)

Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan.

Arata Tsutsumida (A)

Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan.

Shusuke Yoshikawa (S)

Department of Dermatology, Shizuoka Cancer Center Hospital, Sunto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH